Schistosoma haematobium and bladder cancer: What lies beneath?

Virulence

Volumn 1, Issue 2, 2010, Pages 84-87

  Botelho, Monica Catarina ^a,b   Machado, Jose Carlos ^b,c   da Costa, Jose Manuel Correia ^a  

^a NATIONAL INSTITUTE OF HEALTH   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c University of Porto   (Portugal)

Author keywords

Animal models; Carcinogenesis associated phenotypes; CHO cells; Estrogenic DNA adducts; Kras mutations; Schistosoma haematobium; Squamous cell carcinoma of the bladder

Indexed keywords

PROTEIN BCL 2; PROTEIN P27;

APOPTOSIS; ARTICLE; BLADDER CANCER; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHO CELL; HUMAN; IN VITRO STUDY; NONHUMAN; PHENOTYPE; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; UPREGULATION;

ANIMALIA; PLATYHELMINTHES; SCHISTOSOMA HAEMATOBIUM;

EID: 77954899218     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.1.2.10487     Document Type: Article

References (14)

1. Mostafa MH, Sheweita SA, O'Connor PJ. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev 1999; 12:97-111.
2. Botelho M, Ferreira AC, Oliveira MJ, Domingues A, Machado JC, da Costa JM. Schistosoma haematobium total antigen induces increased proliferation, migra tion and invasion, and decreases apoptosis of normal epithelial cells. Int J Parasitol 2009; 39:1083-91.
3. Botelho M, Oliveira P, Gomes J, Gartner F, Lopes C, Correia da Costa JM, et al. Tumourigenic effect of Schistosoma haematobium total antigen in mam malian cells. Int J Exp Path 2009; 90:448-53.
4. Oliveira PA, Colaco_A,De la ruz PLF, Lopes C. Experimental bladder carcinogenesis-rodent models. Exp Oncol 2006; 28:2-11.
5. Botelho MC, Oliveira PA, Lopes C, Correia da Costa JM, Machado JC. Urothelial dysplasia and inflam mation induced by Schistosoma haematobium total antigen instillation in mice normal urothelium. Urol Oncol 2009; In press.
6. Wu XR. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 2005; 5:713-25.
7. Adjei AA. Blocking oncogenic Ras signaling for cancer therapy. J Natl Cancer Inst 2001; 93:1062-74.
8. Botelho MC, Crespo M, Almeida A, Vieira P, Delgado ML, Araujo L, et al. Schistosoma haemato bium and Schistosomiasis mansoni: production of an estradiol-related compound detected by ELISA. Exp Parasitol 2009; 122:250-3.
9. Stack DE, Byun J, Gross ML, Rogan EG, Cavalieri EL. Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem Res Toxicol 1996; 9:851-9.
10. Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, et al. Molecular origin of cancer: catechol estrogen-3-4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 1997; 94:10937-42.
11. Akanni A, Tabakovic K, Abul-Hajj YJ. Estrogen-nucleic acid adducts: reaction of 3,4-estrone-o-quino-ne with nucleic acid bases. Chem Res Toxicol 1997; 10: 477-81.
12. Akanni A, Abul-Hajj YJ. Estrogen-nucleic acid adducts: reaction of 3,4-estrone-o-quinoneradical anion with beoxyribonucleosides. Chem Res Toxicol 1997; 10:760-6.
13. Farmer PB, Sweetman GMA. Special feature: perspective. Mass spectrometry of carcinogen adducts. J Mass Spectrom 1995; 30:1369-79.
14. Zahid M, Kohli E, Saeed M, Rogan E, Cavalieri E. The greater reactivity of estradiol vs. estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity. Chem Res Toxicol 2006; 19:164-72.